Accessibility Menu
 

Camurus Ab (publ)

(OTC) CAMRF

Current Price$55.00
Market Cap$3.27B
Since IPO (2017)+257%
5 Year+326%
1 Year-8%
1 Month-5%

Camurus Ab (publ) Financials at a Glance

Market Cap

$3.27B

Revenue (TTM)

$2.26B

Net Income (TTM)

$734.24M

EPS (TTM)

$1.24

P/E Ratio

43.60

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$55.00

Volume

60

Open

$55.00

Previous Close

$55.00

Daily Range

$55.00 - $55.00

52-Week Range

$52.31 - $71.07

CAMRF News

No articles available.

CAMRF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Camurus Ab (publ)

Industry

Pharmaceuticals

Employees

278

CEO

Sven Fredrik Tiberg, PhD

Headquarters

Lund, 223 70, SE

CAMRF Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

39%

Net Income Margin

32%

Return on Equity

20%

Return on Capital

20%

Return on Assets

16%

Earnings Yield

2.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.27B

Shares Outstanding

59.45M

Volume

60

Short Interest

0.00%

Avg. Volume

18.131

Financials (TTM)

Gross Profit

$2.11B

Operating Income

$873.93M

EBITDA

$963.86M

Operating Cash Flow

$869.30M

Capital Expenditure

$138.52M

Free Cash Flow

$730.78M

Cash & ST Invst.

$3.73B

Total Debt

$106.03M

Camurus Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$464.46M

-16.0%

Gross Profit

$428.09M

-17.6%

Gross Margin

92.17%

N/A

Market Cap

$3.27B

N/A

Market Cap/Employee

$13.74M

N/A

Employees

238

N/A

Net Income

$100.88M

-31.4%

EBITDA

$135.07M

-28.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.62B

+27.7%

Accounts Receivable

$600.38M

+14.7%

Inventory

$111.62M

-20.4%

Long Term Debt

$85.90M

+1103.4%

Short Term Debt

$20.13M

+103.2%

Return on Assets

15.52%

N/A

Return on Invested Capital

20.15%

N/A

Free Cash Flow

$209.64M

+151.5%

Operating Cash Flow

$255.43M

+147.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNNSFGenscript Biotech Corporation
$1.42+0.00%
SNPHFSanten Pharmaceutical Co., Ltd.
$10.99+0.00%
TLPPFTelix Pharmaceuticals Limited
$8.72-2.37%
AMBBYAmbu A/S
$10.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.92+0.08%
ONDSOndas
$9.44-0.08%

Questions About CAMRF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.